Exchange: OTC·Updated 08:05 AM EDT
PPCB logo

PPCB Propanc Biopharma Inc

$1.02
$0.00
(0.00%)
Pre-Market
Prev Close $1.02
Mkt Cap$3.57M
Vol22,184.00

About PPCB

Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.
45

Neutral Sentiment

How do you feel about PPCB?

Advertisement|Remove ads.